# Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

> **NCT00749697** · NA · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 10 (estimated)

## Conditions studied

- Thyroid Carcinoma
- Metastatic Sites Lung Bone Nodal

## Interventions

- **OTHER:** SPECT scan

## Key facts

- **NCT ID:** NCT00749697
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2008-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749697, "Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00749697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*